ClassID:

95620

C07D513/08 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or  -  in which the condensed system contains two hetero rings Bridged systems

Recent Application in this class:
#1
20260008784
2026-01-08

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES

#2
20250230127
2025-07-17

MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS

#3
20250197421
2025-06-19

MCL1 INHIBITORS

#4
20250154168
2025-05-15

SALTS AND POLYMORPHS OF CERTAIN MCL-1 INHIBITORS

#5
20240317721
2024-09-26

PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN

#6
20240199646
2024-06-20

REDOX ACTIVE MATERIALS, PROCESSES AND USES THEREOF

#7
20240182414
2024-06-06

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#8
20240059702
2024-02-22

Macrocyclic compounds for treatment of medical disorders

#9
20230357274
2023-11-09

Salts and polymorphs of certain MCL-1 inhibitors

#10
20230348494
2023-11-02

MCL1 inhibitors

#11
20230312602
2023-10-05

SALT FORMS AND SOLVATES OF MCI-1 ANTAGONISTS

#12
20230271981
2023-08-31

Compounds that inhibit MCL-1 protein

#13
20230183164
2023-06-15

Synthesis of Vinyl Cyclobutyl Intermediates

#14
20230099739
2023-03-30

JAK KINASE INHIBITOR AND PREPARATION AND APPLICATION THEREOF

#15
20220411441
2022-12-29

Redox active materials, processes and uses thereof

#16
20220251113
2022-08-11

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

#17
20220017538
2022-01-20

THIOESTER PRODRUGS OF MACROCYCLES AS INHIBITORS OF HISTONE DEACETYLASES

#18
20210300934
2021-09-30

Macrocyclic compounds for treatment of medical disorders

#19
20210171543
2021-06-10

MCL1 inhibitors

#20
20210171462
2021-06-10

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#21
20210147475
2021-05-20

Method for producing cyclic organic compound

#22
20210115066
2021-04-22

Dithio ETP derivatives

#23
20210040120
2021-02-11

Compounds that inhibit MCL-1 protein

#24
20210009607
2021-01-14

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

#25
20200317693
2020-10-08

Thioester prodrugs of macrocycles as inhibitors of histone deacetylases

#26
20200270209
2020-08-27

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#27
20200231601
2020-07-23

1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use

#28
20200148651
2020-05-14

Substituted phenyloxazolidinones for antimicrobial therapy

#29
20200062780
2020-02-27

Compounds that inhibit Mcl-1 protein

#30
20200002347
2020-01-02

Macrocyclic compounds for treatment of medical disorders

#31
20190382417
2019-12-19

Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia

#32
20190298732
2019-10-03

Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension

#33
20190276462
2019-09-12

[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors

#34
20190211034
2019-07-11

Dithio ETP derivatives

#35
20190177339
2019-06-13

Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia

#36
20190161501
2019-05-30

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

#37
20190023720
2019-01-24

Compounds that inhibit MCL-1 protein

#38
20190016736
2019-01-17

Compounds that inhibit Mcl-1 protein

#39
20180362468
2018-12-20

Opioid agonists and uses thereof

#40
20180346419
2018-12-06

Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

#41
20180305377
2018-10-25

Epidithiodioxopiperazine compound or its derivatives, and the use thereof

#42
20180127375
2018-05-10

Morphinan derivatives for the treatment of neuropathic pain

#43
20180118764
2018-05-03

Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia

#44
20170313716
2017-11-02

Oridonin analogs, compositions, and methods related thereto

#45
20170253565
2017-09-07

Opioid agonists and uses thereof

#46
20170088560
2017-03-30

Compounds that inhibit Mcl-1 protein

#47
20170073354
2017-03-16

Piperazine derivatives as HIV protease inhibitors

#48
20170022167
2017-01-26

Opioid agonists and uses thereof

#49
20160222031
2016-08-04

Epidithiodioxopiperazine compound or its derivatives, and the use thereof

#50
20160200721
2016-07-14

Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity

#51
20160176849
2016-06-23

N-cyanomethylamides as inhibitors of janus kinase

#52
20160122363
2016-05-05

6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

#53
20160096844
2016-04-07

Oridonin analogs, compositions, and methods related thereto

#54
20160068545
2016-03-10

Compounds that inhibit MCL-1 protein

#55
20160060234
2016-03-03

Cysteine derivative

#56
20150252059
2015-09-10

BRIDGED BICYCLIC AMINO THIAZINE DIOXIDE COMPOUNDS AS INHIBITORS OF BETA-SECRETASE AND METHODS OF USE THEREOF

#57
20150246933
2015-09-03

Compositions and methods for inhibiting activity of hypoxia-inducible transcription factor complex and its use for treatment of tumors

#58
20150099719
2015-04-09

Cathepsin cysteine protease inhibitors

#59
20150051197
2015-02-19

Heterocyclic compound and use thereof

#60
20150038497
2015-02-05

Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereof

#61
20140343032
2014-11-20

6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

#62
20140088016
2014-03-27

Macrocyclic therapeutic agents and methods of treatment

#63
20130267511
2013-10-10

Macrocyclic indoles as hepatitis C virus inhibitors

#64
20130095048
2013-04-18

Cysteine derivative

#65
20130065114
2013-03-14

POLYMER ELECTROLYTE, MANUFACTURING METHOD FOR POLYMER ELECTROLYTE, IMIDE MONOMER, AND BATTERY

#66
20130045925
2013-02-21

Compositions for ameliorating cell proliferative disorders and methods of making and using them

#67
20120322791
2012-12-20

Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors

#68
20120309960
2012-12-06

Macrocycles as factor XIa inhibitors

#69
20120295941
2012-11-22

Method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof

#70
20120289501
2012-11-15

Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls

#71
20120041190
2012-02-16

Macrocycles as factor XIa inhibitors

#72
20110294801
2011-12-01

Macrocyclics pyrimidines as aurora kinase inhibitors

#73
20110178055
2011-07-21

Dual NK1/NK3 receptor antagonists

#74
20110060021
2011-03-10

HISTONE DEACETYLASE INHIBITORS AND USES THEREOF

#75
20110053994
2011-03-03

Potent immunosuppressive agents, derivatives and uses

#76
20100273792
2010-10-28

Macrocyclic indoles as hepatitis C virus inhibitors

#77
20100166839
2010-07-01

NON PEPTIDIC RENIN INHIBITORS NITRODERIVATIVES

#78
20100113757
2010-05-06

Macrolide antibiotics and their use for medical purposes

#79
20100093814
2010-04-15

Compounds as cannabinoid receptor ligands and uses thereof

#80
20100056510
2010-03-04

Macrocyclic compound

#81
20100022500
2010-01-28

Macrocyclic Lactams and Pharmaceutical Use Thereof

#82
20090306123
2009-12-10

Bicyclononene derivatives

#83
20090264421
2009-10-22

Methods and Compositions for Treating Cancer

#84
20090186871
2009-07-23

Tyrosine kinase inhibitors

#85
20090170172
2009-07-02

Recombinant methods and materials for producing epothilone and epothilone derivatives

#86
20090137806
2009-05-28

Dual NK1/NK3 receptor antagonists

#87
20090111151
2009-04-30

Production of Polyketides

#88
20090048239
2009-02-19

Therapeutic compounds

#89
20090005373
2009-01-01

SUBSTITUTED SULFONAMIDO-MACROCYCLES AS TIE2 INHIBITORS AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

#90
20080039482
2008-02-14

SULFONAMIDO-MACROCYCLES AS TIE2 INHIBITORS AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

#91
20070275973
2007-11-29

ARYL FUSED AZAPOLYCYCLIC COMPOUNDS

#92
20070262298
2007-11-15

Photosensing soluble organic semiconductor material

#93
20070149581
2007-06-28

Anticancer agents and use

#94
20070135405
2007-06-14

Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain

#95
20070072792
2007-03-29

Macrocyclic lactams and pharmaceutical use thereof

#96
20070027317
2007-02-01

Hetero diels-alder adducts of pentacene as soluble precursors of pentacene

#97
20060258648
2006-11-16

9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors

#98
20060252782
2006-11-09

Sulfoximine-macrocycle compounds and salts thereof, pharmaceutical compositions comprising said compounds, methods of preparing same and uses of same

#99
20060223151
2006-10-05

Production of polyketides

#100
20060194823
2006-08-31

Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof

#101
20060167030
2006-07-27

Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof

#102
20050277684
2005-12-15

Oxidative activation and episulfonium ion-mediated DNA alkylation-based anticancer

#103
20050261496
2005-11-24

Tyrosine kinase inhibitors

#104
20050222143
2005-10-06

Helix mimetics and composition and methods related thereto

#105
20050090533
2005-04-28

Dual NK1/NK3 receptor antagonists

#106
20050020616
2005-01-27

Aryl fused azapolycyclic compounds